Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodecane SCHEMBL7801580 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL9178859 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL11761608 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL5183196 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL9180827 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL9187254 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL9185247 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL9181739 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL9184839 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 | |
| SCHEMBL9186713 | 0.87 | GPR84 (0.54) | GPR84LMNAFFAR1FFAR4SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6177469-B1 | ANTIUTOR AGENTS; AUTOIMMUNE DISEASES | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2001-01-23 | — | — | US | claimed |
| EP-0854708-B1 | LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2001-12-12 | — | — | EP | disclosed |
| US-6177469-B1 | ANTIUTOR AGENTS; AUTOIMMUNE DISEASES | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2001-01-23 | — | — | US | disclosed |
| EP-0416401-B1 | Use of derivatives of phospholipides as antiviral pharmaceuticals and phospholipides | BOEHRINGER MANNHEIM GMBH (DE) | 1996-10-30 | — | — | EP | disclosed |
| US-5158942-A | PROCESS OF USING PHOSPHOLIPID DERIVATIVES TO INHIBIT MULTIPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS | BOEHRINGER MANNHEIM GMBH (DE) | 1992-10-27 | — | — | US | disclosed |